What Are the Benefits of Treating Rheumatoid Arthritis Patients to Remission After Achieving Low Disease Activity in Clinical Practice?

被引：0
|
作者：
Zhao, Jing [1 ]
Sbarigia, Urbano [2 ]
Kwong, Jackie [1 ]
Naik, Chinmayi [3 ]
Zazzetti, Federico [4 ]
Shadick, Nancy [3 ]
Weinblatt, Michael [5 ]
机构：
[1] Janssen Global Serv LLC, Raritan, NJ USA
[2] Johnson & Johnson Innovat Med, Brussels, Belgium
[3] Brigham & Womens Hosp, Boston, MA USA
[4] Johnson & Johnson Innovat Med, Horsham, PA USA
[5] Harvard Med Sch, Brigham & Womens Hosp, Waban, MA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1743
引用
收藏
页码：3559 / 3561
页数：3
相关论文
共 50 条
  • [21] Economic benefits of achieving clinical and radiographic remission with etanercept in patients with rheumatoid arthritis: An analysis using TEMPO data
    Taylor, M
    Trueman, P
    Reynolds, AV
    Pearce, D
    Conway, P
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S549 - S549
  • [22] Economic benefits of etanercept for achieving clinical and radiographic remission in patients with rheumatoid arthritis: An analysis using tempo data
    Taylor, M.
    Trueman, P.
    Conway, P.
    Pearce, D.
    Reynolds, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 505 - 505
  • [23] Treatment Adjustment Strategy after Achieving Remission or Low Disease Activity in Rheumatoid Arthritis : A Systematic Review and Meta-Analysis.
    Henaux, Sophie
    Barnetche, Thomas
    Witrand, Adeline Ruyssen
    Fautrel, Bruno
    Cantagrel, Alain G.
    Constantin, Arnaud
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1083 - S1083
  • [24] RHEUMATOID ARTHRITIS Defining remission in patients with RA in clinical practice
    Westhovens, Rene
    Verschueren, Patrick
    NATURE REVIEWS RHEUMATOLOGY, 2012, 8 (08) : 445 - 447
  • [25] The Clinical and Economic Costs of Not Achieving Remission in Rheumatoid Arthritis
    Curtis, Jeffrey R.
    Chen, Lang
    Kilgore, Meredith
    Yun, Huifeng
    Greenberg, Jeffrey D.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [26] The Clinical and Economic Costs of Not Achieving Remission in Rheumatoid Arthritis
    Curtis, Jeffrey R.
    Chen, Lang
    Kilgore, Meredith
    Greenberg, Jeffrey D.
    Yun, Huifeng
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 215 - 215
  • [27] The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis
    J. Parantainen
    G. Barreto
    R. Koivuniemi
    H. Kautiainen
    D. Nordström
    E. Moilanen
    M. Hämäläinen
    M. Leirisalo-Repo
    K. Nurmi
    K. K. Eklund
    Arthritis Research & Therapy, 24
  • [28] The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis
    Parantainen, J.
    Barreto, G.
    Koivuniemi, R.
    Kautiainen, H.
    Nordstrom, D.
    Moilanen, E.
    Hamalainen, M.
    Leirisalo-Repo, M.
    Nurmi, K.
    Eklund, K. K.
    ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
  • [29] Prediction of disease flare by biomarkers after discontinuing biologics in patients with rheumatoid arthritis achieving stringent remission
    Kameda, Hideto
    Hirata, Ayako
    Katagiri, Takaharu
    Takakura, Yuto
    Inoue, Yuki
    Takenaka, Sayaka
    Ito, Hideki
    Mizushina, Kennosuke
    Ogura, Takehisa
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [30] Prediction of disease flare by biomarkers after discontinuing biologics in patients with rheumatoid arthritis achieving stringent remission
    Hideto Kameda
    Ayako Hirata
    Takaharu Katagiri
    Yuto Takakura
    Yuki Inoue
    Sayaka Takenaka
    Hideki Ito
    Kennosuke Mizushina
    Takehisa Ogura
    Scientific Reports, 11
12345